Drugmakers such as Amgen and Novartis could get cancer treatments to patients more quickly by using a standard that’s also been criticized as not being a meaningful measurement of effectiveness in testing.
Study the topic in more depth in the AAPS book Challenges in Protein Product Development
To read the full content, please log in with your AAPS member username and password.
Sign InNot a member? Learn more and join today!
AAPS Newsmagazine helps pharmaceutical scientists excel in their jobs by providing current science, news, career advice, member recognition, AAPS offerings, and other valuable contemporary information.
2107 Wilson Blvd. #700
Arlington, VA 22201
AAPS Customer Service